Analyst consensus rating
BioCardia, Inc. Analyst Consensus Rating
BCDA analyst consensus rating, coverage count and price target evidence.
Direct answer
BioCardia, Inc.'s consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.50.
Forecast evidence checked August 11, 2026.
Get free BioCardia, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.94
- Average price target
- $15.50
- High price target
- $25.00
- Low price target
- $6.00
- Target upside
- +1,548.9%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026